Meerten, E. van

patient cancer treatment study score tumor irinotecan survival grade month carcinoma esophageal omeprazole toxicity effect neoadjuvant signi ficantly chemoradiotherapy signi surgery questionnaire baseline disease therapy chemotherapy cell carcinoma result quality esophageal cancer hrqol oncol response difference thyroid metabolite lymph nodes pharmacokinetic tumor cells symptom table level resection capecitabine oesophageal cancer oesophageal dysphagia ficantly radiotherapy cycle nodal chemoradiation neoadjuvant crt postoperatively oncology oxaliplatin neoadjuvant chemoradiotherapy cisplatin lymph phase ii study analysis follow-up scale preoperative interaction neck cancer resectable esophageal cancer trg iv paclitaxel inhibitor toxicitie nodal involvement involvement -38 qlq-c journal specimen regression esophagectomy metastatic trial